Literature DB >> 14668463

The meningococcal vaccine--public policy and individual choices.

Paul A Offit1, Georges Peter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14668463     DOI： 10.1056/NEJMsb035678

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

Authors:  Robert Welte; Caroline L Trotter; W John Edmunds; Maarten J Postma; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.

Authors:  In Ho Park; Ju Ho Youn; In-Hong Choi; Moon H Nahm; Se Jong Kim; Jeon-Soo Shin
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis.

Authors:  Gunnstein Norheim; Manish Sadarangani; Omar Omar; Ly-Mee Yu; Kåre Mølbak; Michael Howitz; Per Olcén; Margaretha Haglund; Arie van der Ende; Andrew J Pollard
Journal:  BMJ Open       Date:  2014-02-10       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.